venetoclax
roche,abbvie
['venetoclax']
long term follow up of venetoclax monotherapy for 17p pts- high proportion of pts with rt as progression event #eha22 
Assistant professor at UNC at Chapel Hill, focused on CLL/SLL and CHIP/CCUS/MDS. Animal and nature lover. Tweets are my own.